Summary
- Current Price
- As of today, SLN price is $9.01, up +23.87% in the most recent trading session on
- Current Price All-Time High
- SLN price is currently -74.27% below its historical high of $35.00 set on
- Market Cap
- SLN current market cap is $425M, up +48.98% over the past 365 days
- PE Ratio
- SLN PE ratio is unknown
- Revenue
- SLN current annual revenue is $560.30K, down -98.71% year-over-year
- Next Earnings
- The next earnings release for SLN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Silence Therapeutics plc |
| Ticker | NASDAQ: SLN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | silence-therapeutics.com |
| Employees | 116 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $9.01 | ||
| Price, 1D Change | +23.87% | |
| $425M | ||
| - | ||
| - | ||
| 1.43 | ||
| $560K | ||
| Revenue, 1Y Change | -98.71% | |
| -$1.88 | ||
| EPS, 1Y Change | -91.87% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.88 | ||
| EPS Estimate | N/A | -$0.40 |
| EPS Est. Change | N/A | +78.73% |
| $560.30K | ||
| Revenue Estimate | N/A | $2.86M |
| Revenue Est. Change | N/A | +410.59% |
| $9.01 | ||
| Price Target | - | $25.00 |
| Price Tgt. Change | - | +177.62% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.85 | -$0.98 | -15.47% | |
| -$1.32 | -$1.88 | -43.00% | |
| -$0.40 | N/A | +78.73% | |
| -$0.39 | N/A | +79.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $19.81M | $43.28M | +118.50% | |
| $5.87M | $560.30K | -90.45% | |
| $2.86M | N/A | +410.59% | |
| $4.13M | N/A | +636.91% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +48.97% | ||
| +35.41% | ||
| +48.98% | ||
| +77.59% | ||
| -98.71% | ||
| -97.40% | ||
| -91.87% | ||
| -21.39% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $9.01 | ||
| $6.11 | ||
| $6.90 | ||
| $6.38 | ||
| $6.64 | ||
| $0.12 | ||
| 1.43 | ||
| $0.58 | ||
| 57.66 | ||
| 82.86% | ||
| 75.28% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $560.30K | ||
| -$1.88 | ||
| -$55.10K | ||
| -9.83% | ||
| -$82.48M | ||
| -14.72% | ||
| -$88.82M | ||
| -15.85% | ||
| -$81.93M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 8.72 | ||
| 8.72 | ||
| - | ||
| 3 | ||
| -3.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 506.31 | ||
| 8.61 | ||
| -5.00 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $62.30M | ||
| $85.11M | ||
| $131.44M | ||
| $118.66M | ||
| $69.14M | ||
| $13.61M | ||
| $160.00K | ||
| $89.00K | ||
| $4.41M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $89.38M | ||
| $82.43M | ||
| $615.40K | ||
| $0.00 | ||
| $556.30K | ||
| $0.00 | ||
| $11.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$62.42M | ||
| -$48.10M | ||
| $15.00K | ||
| $55.10K | ||
| -$62.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SLN
FAQ
What is the ticker symbol for Silence Therapeutics plc?
The ticker symbol for Silence Therapeutics plc is NASDAQ:SLN
Does Silence Therapeutics plc pay dividends?
No, Silence Therapeutics plc does not pay dividends
What sector is Silence Therapeutics plc in?
Silence Therapeutics plc is in the Healthcare sector
What industry is Silence Therapeutics plc in?
Silence Therapeutics plc is in the Biotechnology industry
What country is Silence Therapeutics plc based in?
Silence Therapeutics plc is headquartered in United Kingdom
When did Silence Therapeutics plc go public?
Silence Therapeutics plc initial public offering (IPO) was on September 8, 2020
Is Silence Therapeutics plc in the S&P 500?
No, Silence Therapeutics plc is not included in the S&P 500 index
Is Silence Therapeutics plc in the NASDAQ 100?
No, Silence Therapeutics plc is not included in the NASDAQ 100 index
Is Silence Therapeutics plc in the Dow Jones?
No, Silence Therapeutics plc is not included in the Dow Jones index
When was Silence Therapeutics plc last earnings report?
Silence Therapeutics plc's most recent earnings report was on May 7, 2026
When does Silence Therapeutics plc report earnings?
The next expected earnings date for Silence Therapeutics plc is August 6, 2026
Data Sources & References
- SLN Official Website www.silence-therapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1479615/000119312526092591/0001193125-26-092591-index.htm
- SLN Profile on Yahoo Finance finance.yahoo.com/quote/SLN
- SLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sln